NCT02526186

Brief Summary

We will conduct a randomized controlled trial to determine whether the addition of battlefield auricular acupuncture to standard of care is effective for control of postpartum pain for mothers in the immediate post-partum period. Post-partum patients (DoD beneficiaries) 18 years or older, regardless of gravida/parity, who plan to have a childbirth in a hospital setting will be offered the opportunity to participate in the study through PCM referrals and posted advertisements. After a minimum of 6 hours post-vaginal delivery or 24 hours post caesarean section subjects will be given treatment according to their randomization group. Subjects will be assessed on pain control, overall satisfaction with pain management, and the amount of pharmacological pain medications used. Safety of measures will also be assessed to include infection rates, syncope, vertigo, and hypotension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable pain

Timeline
Completed

Started Feb 2016

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 18, 2015

Completed
6 months until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2018

Completed
5.9 years until next milestone

Results Posted

Study results publicly available

March 27, 2024

Completed
Last Updated

March 27, 2024

Status Verified

February 1, 2024

Enrollment Period

2.3 years

First QC Date

August 14, 2015

Results QC Date

January 16, 2024

Last Update Submit

February 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Subjects Who Achieved 50% Sustained Pain Reduction

    measured daily from days 0-11.

    12 days

Secondary Outcomes (1)

  • Morphine Equivalent Use

    12 days

Study Arms (2)

Standard of Care

NO INTERVENTION

Standard of Care only

Battlefield Auricular Acupuncture

EXPERIMENTAL

Standard of Care plus Battlefield Auricular Acupuncture

Device: Battlefield Auricular Acupuncture

Interventions

Battlefield Auricular Acupuncture

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Post-partum female (DoD beneficiaries).
  • Age 18 years or older
  • Pain score rating post-delivery of greater or equal to 4/10.

You may not qualify if:

  • Absence of one or more ears
  • Active cellulitis of ear
  • Ear anatomy precluding identification of acupuncture landmarks
  • Non-English speaking
  • Use of Hearing Aids that preclude the use of ear acupuncture
  • Known allergy to gold

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mike O'Callaghan Federal Medical Center

Nellis Air Force Base, Nevada, 89191, United States

Location

Related Publications (2)

  • Deussen AR, Ashwood P, Martis R, Stewart F, Grzeskowiak LE. Relief of pain due to uterine cramping/involution after birth. Cochrane Database Syst Rev. 2020 Oct 20;10(10):CD004908. doi: 10.1002/14651858.CD004908.pub3.

  • Zimpel SA, Torloni MR, Porfirio GJ, Flumignan RL, da Silva EM. Complementary and alternative therapies for post-caesarean pain. Cochrane Database Syst Rev. 2020 Sep 1;9(9):CD011216. doi: 10.1002/14651858.CD011216.pub2.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Amanda Crawford
Organization
MOMH

Study Officials

  • Michael J Kim, MD

    Mike O'Callaghan Federal Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2015

First Posted

August 18, 2015

Study Start

February 1, 2016

Primary Completion

May 20, 2018

Study Completion

May 20, 2018

Last Updated

March 27, 2024

Results First Posted

March 27, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations